Aromatase and 5α-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 3, 2009, Pages 973-981

  Veldhuis, Johannes D ^a,b   Mielke, Kristi L ^a,b   Cosma, Mihaela ^a,b   Soares Welch, Cacia ^a,b   Paulo, Remberto ^a,b   Miles, John M ^a,b   Bowers, Cyril Y ^c  

^a Center for Clinical and Translational Sciences   (United States)

^b MAYO CLINIC   (United States)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ARGININE; AROMATASE; DUTASTERIDE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PLACEBO; PRALMORELIN; SEX HORMONE; SOMATOSTATIN; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; AROMATASE INHIBITOR; CHOLESTENONE 5ALPHA REDUCTASE; ESTRADIOL; HUMAN GROWTH HORMONE;

ADULT; AGED; AROMATIZATION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; FEEDBACK SYSTEM; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRAABDOMINAL FAT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SECRETION; STATISTICAL MODEL;

AGED; AROMATASE INHIBITORS; CHOLESTENONE 5 ALPHA-REDUCTASE; DOUBLE-BLIND METHOD; ESTRADIOL; HUMAN GROWTH HORMONE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SOMATOSTATIN; TESTOSTERONE;

EID: 62349124646     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2108     Document Type: Article

References (61)

1. Veldhuis JD, Roemmich JN, Richmond EJ, Bowers CY 2006 Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition. Endocr Rev 27:101-140
2. Giustina A, Veldhuis JD 1998 Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797
3. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 2000 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
4. Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E 2001 Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 86:1169-1174
5. Bowers CY 1999 GH releasing peptides (GHRPs). Kostyo J, Goodman H, eds. Handbook of physiology. New York: Oxford University Press; 267-297
6. Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG, Kangawa K, Grossman AB 2001 The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 86:881-887
7. Shuto Y, Shibasaki T, Otagiri A, Kuriyama H, Ohata H, Tamura H, Kamegai J, Sugihara H, Oikawa S, Wakabayashi I 2002 Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 109:1429-1436
8. Di Vito L, Broglio F, Benso A, Gottero C, Prodam F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Ghigo E, Arvat E 2002 The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. Clin Endocrinol (Oxf) 56:643-648
9. Veldhuis JD, Evans WS, Bowers CY 2003 Estradiol supplementation enhances submaximal feedforward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-l,44-amide in a putatively somatosta-tin-withdrawn milieu. J Clin Endocrinol Metab 88:5484-5489
10. Anderson SM, Shah N, Evans WS, Patrie JT, Bowers CY, Veldhuis JD 2001 Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women. J Clin Endocrinol Metab 86:551-560
11. Roelfsema F, Biermasz NR, Veldman RG, Veldhuis JD, Frolich M, Stokvis-Brantsma WH, Wit JM 2000 Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab 86:2459-2464
12. Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton MP, Grouselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y, Amselem S 2006 Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 116:760-768
13. Finkelstein JW, Roffwarg HP, Boyar RM, Kream J, Hellman L 1972 Age-related change in the twenty-four-hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab 35:665-670
14. Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD 1998 Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGFT, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men. Eur J Endocrinol 139:59-71
15. Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan T, Johnson ML, Pincus SM, Straume M, Iranmanesh A 1995 Differential impact of age, sex-steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 80:3209-3222
16. Mauras N, Blizzard RM, Link K, Johnson ML, Rogol AD, Veldhuis JD 1987 Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon. J Clin Endocrinol Metab 64:596-601
17. Mauras N, Rogol AD, Veldhuis JD 1990 Increased hGH production rate after low-dose estrogen therapy in prepubertal girls with Turner's syndrome. Pedi-atr Res 28:626-630
18. Metzger DL, Kerrigan JR 1994 Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence. J Clin Endocrinol Metab 79:513-518
19. Metzger DL, Kerrigan JR 1993 Androgen receptor blockade with flutamide enhances growth hormone secretion in late pubertal males: evidence for in-dependent actions of estrogen and androgen. J Clin Endocrinol Metab 76: 1147-1152
20. Gentili A, Mulligan T, Godschalk M, Clore J, Patrie J, Iranmanesh A, Veldhuis JD 2002 Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men. J Clin Endocrinol Metab 87:825-834
21. Weissberger AJ, Ho KK 1993 Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocrinol Metab 76:1407-1412
22. Shah N, Evans WS, Veldhuis JD 1999 Actions of estrogen on the pulsatile, nyctohemeral, and entropic modes of growth hormone secretion. Am J Physiol 276:R1351-R1358
23. Muniyappa R, Sorkin JD, Veldhuis JD, Harman SM, Munzer T, Bhasin S, Blackman MR 2007 Long-term testosterone supplementation augments overnight growth hormone secretion in healthy older men. Am J Physiol Endocrinol Metab 293:E769-E775
24. Veldhuis JD, Keenan DM, Iranmanesh A, Mielke K, Miles JM, Bowers CY 2006 Estradiol potentiates ghrelin-stimulated pulsatile GH secretion in postmenopausal women. J Clin Endocrinol Metab 91:3559-3565
25. Veldhuis JD, Anderson SM, Patrie JT, Bowers CY 2004 Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive. J Clin Endocrinol Metab 89:121-127
26. Bray MJ, Vick TM, Shah N, Anderson SM, Rice LW, Iranmanesh A, Evans WS, Veldhuis JD 2001 Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion. J Clin Endocrinol Metab 86:3143-3149
27. Rigamonti AE, Cella SG, Giordani C, Bonomo SM, Giunta M, Sartorio A, Muller E 2006 Testosterone inhibition of growth hormone release stimulated by a growth hormone secretogogue: studies in the rat and dog. Neuroendo-crinology 84:115-122
28. Veldhuis JD, Keenan DM, Mielke K, Miles JM, Bowers CY 2005 Testosterone supplementation in healthy older men drives GH and 1GF-1 secretion without potentiating peptidyl secretagogue efficacy. Eur J Endocrinol 153:577-586
29. Loche S, Colao A, Cappa M, Bellone J, Aimaretti G, Farello G, Faedda A, Lombardi G, Deghenghi R, Ghigo E 1997 The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids. J Clin Endocrinol Metab 82:861-864
30. Fryburg DA, Weltman A, Jahn LA, Weltman JY, Samolijik E, Veldhuis JD 1997 Short-term modulation of the androgen milieu alters pulsatile but not exercise or GHRH-stimulated GH secretion in healthy men. J Clin Endocrinol Metab 82:3710-3719
31. Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER 1993 Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotes-tosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab 76:996-1001
32. Paulo RC, Cosma M, Soares-Welch CV, Bailey JN, Mielke KL, Miles JM, Bowers CY, Veldhuis JD 2008 Gonadal status and body-mass index jointly determine GHRH/GHRP synergy in healthy men. J Clin Endocrinol Metab 93:944-950
33. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I 2001 Estrogen receptor (ER)α, but not ERα, gene is expressed in growth hormone-releasing hormone neurons of the male rat hypothalamus. Endocrinology 142:538-543
34. Yan M, Jones ME, Hernandez M, Liu D, Simpson ER, Chen CH 2004 Functional modification of pituitary somatotropes in the aromatase knockout mouse and the effect of estrogen replacement. Endocrinology 145:604-612
35. Kimura N, Tomizawa S, Arai KN, Kimura N 1998 Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries. Endocrinology 139:1573-1580
36. Sanford M, Plosker GL 2008 Anastrozole: a review of its use in postmenopausal women with early-stage breast cancer. Drugs 68:1319-1340
37. Keam SJ, Scott LJ 2008 Dutasteride: a review of its use in the management of prostate disorders. Drugs 68:463-485
38. Veldhuis JD, Erkkson D, Mielke K, Farhy LS, Keenan DM, Bowers CY 2005 Distinctive inhibitory mechanisms of age and relative visceral adiposity on GH secretion in pre- and postmenopausal women studied under a hypogonadal clamp. J Clin Endocrinol Metab 90:6006-6013
39. Paulo RC, Brundage R, Cosma M, Mielke KL, Bowers CY, Veldhuis JD 2008 Estrogen elevates the peak overnight production rate of acylated ghrelin. J Clin Endocrinol Metab 93:4440-4447
40. Cosma M, Bailey JN, Miles JM, Bowers CY, Veldhuis JD 2008 Pituitary and/or peripheral estrogen-receptor α (ERα) regulates FSH secretion whereas central pathways direct GH and prolactin secretion in postmenopausal women. J Clin Endocrinol Metab 93:951-958
41. Keenan DM, Roelfsema F, Biermasz N, Veldhuis JD 2003 Physiological control of pituitary hormone secretory-burst mass, frequency and waveform: a statistical formulation and analysis. Am J Physiol 285:R664-R673
42. Faria ACS, Veldhuis JD, Thorner MO, Vance ML 1989 Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin. J Clin Endocrinol Metab 68:535-541
43. Anderson SM, Wideman L, Patrie JT, Weltman A, Bowers CY, Veldhuis JD 2001 Estradiol supplementation selectively relieves GH's autonegative feedback on GH-releasing peptide-2-stimulated GH secretion. J Clin Endocrinol Metab 86:5904-5911
44. Petersenn S, Rasch AC, Penshorn M, Beil FU, Schulte HM 2001 Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor. Endocrinology 142:2649-2659
45. Djordjijevic D, Zhang J, Priam M, Viollet C, Gourdji D, Kordon C, Epelbaum J 1998 Effect of 17β-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures. Endocrinology 139:2272-2277
46. Childs GV, Iruthayanathan M, Akhter N, Unabia G, Whitehead-Johns on B 2005 Bipotential effects of estrogen on growth hormone synthesis and storage in vitro. Endocrinology 146:1780-1788
47. Scanlan N, Dufourny L, Skinner DC 2003 Somatostatin-14 neurons in the ovine hypothalamus: colocalization with estrogen receptor α and somatosta-tin-28(l-12) immunoreactivity, and activation in response to estradiol. Biol Reprod 69:1318-1324
48. Bouyer K, Loudes C, Robinson IC, Epelbaum J, Faivre-Bauman A 2006 Sexually dimorphic distribution of SST2A receptors on GHRH neurons in mice. Endocrinology 147:2670-2674
49. Clegg DJ, Brown LM, Zigman JM, Kemp CJ, Strader AD, Benoit SC, Woods SC, Mangiaracina M, Geary N 2007 Estradiol-dependent decrease in the orexigenic potency of ghrelin in female rats. Diabetes 56:1051-1058
50. De Marinis L, Mancini A, Izzi D, Bianchi A, Giampietro A, Fusco A, Liberale I, Rossi S, Valle D 2000 Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer. Clin Endocrinol (Oxf) 52:681-685
51. Corsello SM, Rota CA, Putignano P, Delia CS, Barnabei A, Migneco MG, Vangeli V, Barini A, Mandala M, Barone C, Barbarino A 1998 Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer. Eur J Endocrinol 139:309-313
52. Veldhuis JD, Keenan DM, Bowers CY 2007 Peripheral estrogen receptor-α selectively modulates the waveform of GH secretory bursts in healthy women. Am J Physiol Regul lntegr Comp Physiol 293:R1514-R1521
53. Cho SJ, Jeftinija K, Glavaski A, Jeftinija S, Jena BP, Anderson LL 2002 Structure and dynamics of the fusion pores in live GH-secreting cells revealed using atomic force microscopy. Endocrinology 143:1144-1148
54. Lam KS, Lee MF,Tam SP, Srivastava G 1996 Gene expression of the receptor for growth-hormone-releasing hormone is physiologically regulated by glucocorticoids and estrogen. Neuroendocrinology 63:475-480
55. Tena-Sempere M, Gonzalez LC, Pinilla L, Huhtaniemi I, Aguilar E 2001 Neonatal imprinting and regulation of estrogen receptor α and β mRNA expression by estrogen in the pituitary and hypothalamus of the male rat. Neuroendocrinology 73:12-25
56. Aguilar E, Tena-Sempere M, Pinilla L 1992 5α-Androstanediol stimulates the pituitary growth hormone responsiveness to growth hormone releasing hormone more effectively than testosterone or dihydrotestosterone in rats. Acta Endocrinol (Copenh) 126:162-166
57. Lund TD, Hinds LR, Handa RJ 2006 The androgen 5α- dihydrotestosterone and its metabolite 5α-androstan-3α,17β-diol inhibit the hypothalamo-pitu-itary-adrenal response to stress by acting through estrogen receptor β-express-ing neurons in the hypothalamus. J Neurosci 26:1448-1456
58. Orrego JJ, Dimaraki E, Symons K, Barkan AL 2004 Physiological testosterone replenishment in healthy elderly men does not normalize pituitary growth hormone output: evidence against the connection between senile hypogonadism and somatopause. J Clin Endocrinol Metab 89:3255-3260
59. Bondanelli M, Ambrosio MR, Margutti A, Franceschetti P, Zatelli MC, degli Uberti EC 2003 Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone. Neuroendocrinology 77:380-387
60. Liu L, Merriam GR, Sherins RJ 1987 Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 64:651-656
61. Veldhuis JD, Evans WS, Iranmanesh A, Weltman AL, Bowers CY 2004 Short-term testosterone supplementation relieves growth hormone autonegative feedback in men. J Clin Endocrinol Metab 89:1285-1290